Michitaka Tanaka Selected Research

Flatulence

1/2019	Reduction of Excessive Visceral Fat and Safety with 52-Week Administration of Lipase Inhibitor Orlistat in Japanese: Long-Term Clinical Study.
1/2019	Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michitaka Tanaka Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 09/2013
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2021
2	Hypersensitivity (Allergy) 10/2021 - 02/2013
2	Metrorrhagia (Spotting) 01/2019 - 01/2019
2	Dyslipidemias (Dyslipidemia) 01/2019 - 01/2019
2	Hypertension (High Blood Pressure) 01/2019 - 01/2019
2	Diabetes Mellitus 01/2019 - 01/2019
2	Metabolic Diseases (Metabolic Disease) 01/2019 - 01/2019
2	Flatulence 01/2019 - 01/2019
2	Allergic Rhinitis 11/2018 - 06/2013
2	Asthma (Bronchial Asthma) 11/2018 - 02/2013
2	Peritonitis 02/2013 - 06/2012
1	COVID-19 01/2021
1	Infections 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Body Weight (Weight, Body) 01/2019
1	Edema (Dropsy) 02/2018
1	Rhinitis 06/2013
1	Inflammation (Inflammations) 02/2013

Drug/Important Bio-Agent (IBA)

4	OvalbuminIBA 09/2013 - 06/2012
3	Diethylhexyl Phthalate (DEHP)IBA 10/2021 - 02/2013
3	Particulate MatterIBA 01/2021 - 09/2013
3	AllergensIBA 02/2018 - 02/2013
2	Estrogen ReceptorsIBA 01/2022 - 01/2021
2	Orlistat (Xenical)FDA Link 01/2019 - 01/2019
1	perfluorooctanoic acidIBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	4- methyl- 2,4- bis(4- hydroxyphenyl)pent- 1- eneIBA 01/2021
1	Air Pollutants (Pollutants, Air)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	CytokinesIBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	Estrogen Receptor alphaIBA 01/2021
1	Lipase (Acid Lipase)FDA Link 01/2019
1	phthalic acid (phthalate)IBA 06/2013
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 02/2013
1	Chemotactic FactorsIBA 02/2013
1	Interleukin-5 (Interleukin 5)IBA 02/2013
1	Therapeutic UsesIBA 06/2012